Serum Dickkopf-1 and Correlation with Bone Mineral Density in Patients with Beta Thalassemia Major in North-Eastern of Iran

Article history Received 11 Jan 2018 Accepted 15 Jul 2018 Available online 28 Aug 2018

[1]  L. Idolazzi,et al.  Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis , 2016, Calcified Tissue International.

[2]  L. Qiu,et al.  [Detection of serum DKK1 in multiple myeloma and myeloma bone disease]. , 2015, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.

[3]  A. Gulsahi.  Osteoporosis and jawbones in women , 2015, Journal of International Society of Preventive & Community Dentistry.

[4]  S. Perrotta,et al.  Iron overload causes osteoporosis in thalassemia major patients through interaction with transient receptor potential vanilloid type 1 (TRPV1) channels , 2014, Haematologica.

[5]  M. Clynes,et al.  Bone Disease in Multiple Myeloma: Pathophysiology and Management , 2014, Cancer growth and metastasis.

[6]  V. De Sanctis,et al.  Effects of the anti-receptor activator of nuclear factor kappa B ligand denusomab on beta thalassemia major-induced osteoporosis , 2014, Indian journal of endocrinology and metabolism.

[7]  V. Alinejad,et al.  Bone density in transfusion dependent thalassemia patients in Urmia, Iran , 2014, Iranian journal of pediatric hematology and oncology.

[8]  F. Zhou,et al.  Dickkopf-1 is a key regulator of myeloma bone disease: opportunities and challenges for therapeutic intervention. , 2013, Blood reviews.

[9]  C. Hurson,et al.  The role of Dkk1 in bone mass regulation: Correlating serum Dkk1 expression with bone mineral density , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  E. Kastritis,et al.  Serum Dickkopf-1 is increased and correlates with reduced bone mineral density in patients with thalassemia-induced osteoporosis. Reduction post-zoledronic acid administration , 2008, Haematologica.